Literature DB >> 23153004

Evaluation of the association between the ADRA2A genetic polymorphisms and type 2 diabetes in a Chinese Han population.

Tianjie Li1, Xilin Zhu, Xiaopan Wu, Jingyun Li, Liping Pan, Pengtao Li, Zhenhui Xin, Harvest F Gu, Ying Liu.   

Abstract

Alpha-2-adrenergic receptor (ADRA2A) is involved in the sympathetic nervous system and plays a role in the regulation of insulin secretion and lipolysis. Recent studies have indicated that the ADRA2A polymorphisms are associated with type 2 diabetes (T2DM) in Caucasians and African Americans. The present study aimed to evaluate the association between the ADRA2A polymorphisms and T2DM in a Chinese Han population. Two single-nucleotide polymorphisms (SNPs) rs521674 and rs553668 in the ADRA2A gene were genotyped in 2094 Chinese subjects (1042 T2DM patients and 1052 nondiabetic controls) by using the TaqMan allelic discrimination technique. A single-locus analysis indicated that SNP rs553668 was associated with T2DM (p=0.04). Further analysis indicated that the association of SNP rs553668 was found in T2DM patients with body mass index (BMI)<25 kg/m(2) (p=0.03), but not in the patients with BMI≥25 kg/m(2) (p=0.56). This association was still significant in a recessive model (p=0.01, odds ratio=0.68, 95% confidence interval=0.51-0.92). In conclusion, the present study provides evidence that the ADRA2A polymorphism, rs553668, is associated with lean T2DM patients in a Chinese Han population. Further investigation to explore the role of ADRA2A in the regulation of body weight has been taken into our consideration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23153004      PMCID: PMC3501114          DOI: 10.1089/gtmb.2012.0189

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  24 in total

1.  Association of nucleotide patterns with gene function classes: application to human 3' untranslated sequences.

Authors:  Darrell Conklin; Inge Jonassen; Rein Aasland; William R Taylor
Journal:  Bioinformatics       Date:  2002-01       Impact factor: 6.937

2.  Do allelic variants in alpha2A and alpha2C adrenergic receptors predispose to hypertension in blacks?

Authors:  Jia-Ling Li; Russell M Canham; Wanpen Vongpatanasin; David Leonard; Richard J Auchus; Ronald G Victor
Journal:  Hypertension       Date:  2006-04-24       Impact factor: 10.190

3.  Altered glucose homeostasis in alpha2A-adrenoceptor knockout mice.

Authors:  Veronica Fagerholm; Tove Grönroos; Päivi Marjamäki; Tapio Viljanen; Mika Scheinin; Merja Haaparanta
Journal:  Eur J Pharmacol       Date:  2004-11-28       Impact factor: 4.432

4.  Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans.

Authors:  R Duggirala; J Blangero; L Almasy; T D Dyer; K L Williams; R J Leach; P O'Connell; M P Stern
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

5.  Mechanism of sympathetic neural regulation of insulin, somatostatin, and glucagon secretion.

Authors:  T Kurose; Y Seino; S Nishi; K Tsuji; T Taminato; K Tsuda; H Imura
Journal:  Am J Physiol       Date:  1990-01

6.  Genetic variations in the α(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine.

Authors:  Daniel Kurnik; Mordechai Muszkat; Chun Li; Gbenga G Sofowora; Eitan A Friedman; Mika Scheinin; Alastair J J Wood; C Michael Stein
Journal:  Circ Cardiovasc Genet       Date:  2011-02-15

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  Pathogenesis of NIDDM. A balanced overview.

Authors:  R A DeFronzo; R C Bonadonna; E Ferrannini
Journal:  Diabetes Care       Date:  1992-03       Impact factor: 19.112

9.  Variations in the alpha2A-adrenergic receptor gene and their functional effects.

Authors:  Daniel Kurnik; Mordechai Muszkat; Chun Li; Gbenga G Sofowora; Joseph Solus; Hong-Guang Xie; Paul A Harris; Lan Jiang; Chara McMunn; Patrick Ihrie; Elliott P Dawson; Scott M Williams; Alastair J J Wood; C Michael Stein
Journal:  Clin Pharmacol Ther       Date:  2006-02-07       Impact factor: 6.875

10.  Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and Type 2 diabetes. The Finnish Diabetes Prevention Study.

Authors:  N Siitonen; J Lindström; J Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; J Tuomilehto; M Laakso; M Uusitupa
Journal:  Diabetologia       Date:  2004-07-28       Impact factor: 10.122

View more
  4 in total

1.  Alpha2A adrenergic receptor genetic variation contributes to hyperglycemia after myocardial infarction.

Authors:  Abiodun Adefurin; Leon Darghosian; Chimalum Okafor; Vivian Kawai; Chun Li; Anushi Shah; Wei-Qi Wei; Daniel Kurnik; C Michael Stein
Journal:  Int J Cardiol       Date:  2016-04-13       Impact factor: 4.164

2.  Variation in the α(2A) adrenoceptor gene and the effect of dexmedetomidine on plasma insulin and glucose.

Authors:  Laxmi V Ghimire; Mordechai Muszkat; Gbenga G Sofowora; Mika Scheinin; Alastair J J Wood; C Michael Stein; Daniel Kurnik
Journal:  Pharmacogenet Genomics       Date:  2013-09       Impact factor: 2.089

3.  Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients.

Authors:  Annika M A Berends; Mathieu S Bolhuis; Ilja M Nolte; Edward Buitenwerf; Thera P Links; Henri J L M Timmers; Richard A Feelders; Elisabeth M W Eekhoff; Eleonora P M Corssmit; Peter H Bisschop; Harm R Haak; Ron H N van Schaik; Samira El Bouazzaoui; Bob Wilffert; Michiel N Kerstens
Journal:  Biomedicines       Date:  2022-04-13

4.  Evaluation of Association of ADRA2A rs553668 and ACE I/D Gene Polymorphisms with Obesity Traits in the Setapak Population, Malaysia.

Authors:  Vicneswari Shunmugam; Yee-How Say
Journal:  Iran Red Crescent Med J       Date:  2016-02-13       Impact factor: 0.611

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.